CLOVIQU Trademark

Trademark Overview

On Wednesday, December 7, 2016, a trademark application was filed for CLOVIQU with the United States Patent and Trademark Office. The USPTO has given the CLOVIQU trademark a serial number of 87260286. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 9, 2019. This trademark is owned by Kadmon Pharmaceuticals, LLC. The CLOVIQU trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease
cloviqu

General Information

Serial Number87260286
Word MarkCLOVIQU
Filing DateWednesday, December 7, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 9, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 12, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKadmon Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWarrendale, PA 15086
Party NameKadmon Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWarrendale, PA 15086

Trademark Events

Event DateEvent Description
Monday, December 9, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 9, 2019ABANDONMENT - NO USE STATEMENT FILED
Monday, July 8, 2019ASSIGNED TO EXAMINER
Thursday, May 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 7, 2019EXTENSION 3 GRANTED
Tuesday, May 7, 2019EXTENSION 3 FILED
Tuesday, May 7, 2019TEAS EXTENSION RECEIVED
Friday, November 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 7, 2018EXTENSION 2 GRANTED
Wednesday, November 7, 2018EXTENSION 2 FILED
Wednesday, November 7, 2018TEAS EXTENSION RECEIVED
Wednesday, May 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 7, 2018EXTENSION 1 GRANTED
Monday, May 7, 2018EXTENSION 1 FILED
Monday, May 7, 2018TEAS EXTENSION RECEIVED
Tuesday, November 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 27, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 27, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 11, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 11, 2017NON-FINAL ACTION E-MAILED
Saturday, March 11, 2017NON-FINAL ACTION WRITTEN
Friday, March 10, 2017ASSIGNED TO EXAMINER
Monday, December 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 10, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

cloviqu pharmaceutical disease wilson agents preparations treatment